REDWOOD CITY, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Myoscience, Inc. is pleased to announce the addition of Justin Chickles to the team as Vice President of Commercial Development and the promotion of Johanna Beckmen to General Manager of Aesthetics.
Mr. Chickles was most recently the Director of Licensing and Business Development at Purdue Pharma. Prior to Purdue Pharma, Mr. Chickles was a Director at Johnson & Johnson, where he built an agile team dedicated to creating a new market for a non-invasive device treating peripheral nerves.
"Myoscience's iovera° treatment is poised to become a transformative therapy for patients living with pain," said Chickles. "The passion surrounding myoscience is incredible. I've joined at a tipping point for the company and I am enthusiastic about the potential in the therapeutic market."
Ms. Beckmen joined myoscience in June of 2013. In her tenure at myoscience, Ms. Beckmen has been instrumental in developing the iovera° brand and social media strategy. Previously, she had been responsible for the Thermage and Fraxel brands at Solta Medical.
"We have made tremendous progress the past year in preparing for commercial launch," said Clint Carnell, CEO of myoscience. "I am pleased to add such talented individuals to lead our commercial efforts."
ABOUT MYOSCIENCE
Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold TherapyTM, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the patented technology delivered by the ioveraº system. The ioveraº system is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions, and is indicated in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com.
The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=25085
© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience.
MKT-0285 REV A